Themis Raises EUR 40 Million in Series D Financing Round Backed by US/EU Consortium to Support Pivotal Study and Expand Clinical Pipeline

Total Page:16

File Type:pdf, Size:1020Kb

Themis Raises EUR 40 Million in Series D Financing Round Backed by US/EU Consortium to Support Pivotal Study and Expand Clinical Pipeline FOR IMMEDIATE RELEASE Themis Raises EUR 40 Million in Series D Financing Round Backed by US/EU Consortium to Support Pivotal Study and Expand Clinical Pipeline -- Themis well-funded through completion of Chikungunya Phase 3 program -- Vienna, Austria, September 18, 2019—Themis announced today the closing of a Series D financing round totaling EUR 40 million (USD 44 million). The round was co-led by new investors, Farallon Capital and Hadean Ventures. MSD (tradename of Merck & Co., Inc., Kenilworth, N.J., USA) and Adjuvant Capital, as well as current investors Global Health Investment Fund, aws Gruenderfonds, Omnes Capital, Ventech and Wellington Partners Life Sciences, also participated. The proceeds from this Series D round will be used to accelerate the company’s pivotal Phase 3 clinical trial program for its Chikungunya vaccine and to support further expansion into oncology indications using its proprietary measles vaccine vector platform. Concurrent with the financing, Dr. Walter Stockinger, Managing Partner at Hadean Ventures, will join Themis’ Supervisory Board. “The commitment from our new investors Farallon Capital, Adjuvant Capital and Hadean Ventures as well as MSD is a validation of Themis’ achievements and the potential of our platform. This round enables us to continue implementing our strategy to develop novel vaccines and therapeutic candidates for numerous infectious diseases and oncology indications,” said Erich Tauber, MD, CEO of Themis. “The capital will primarily facilitate the progress of our lead vaccine candidate for Chikungunya towards the market as well as fund the further development of our oncology franchise. I would like to thank our current investors for their continued support and also welcome Walter to our Board.” “We are excited about joining a world-class syndicate to support the development of a vaccine that will prevent a devastating disease in millions of people,” stated Walter Stockinger, MS, PhD, Managing Partner of Hadean Ventures. “Clearly, the uniqueness of the platform technology as well as the quality of the management were major criteria for our investment decision. We are looking forward to working with Erich and his colleagues towards achieving approval of the Chikungunya vaccine in the shortest possible time.” Themis’ lead program is a vaccine for Chikungunya, a debilitating disease with global outbreak potential, developed using its measles vaccine vector platform. The vaccine candidate, MV- CHIK, is Phase 3-ready with the pivotal global Phase 3 trial initiation expected in the next few months. The company’s other vaccine programs include those for Zika and Lassa Fever, which are currently being studied in Phase 1 clinical trials, and for Respiratory Syncytial Virus (RSV), Cytomegalovirus (CMV), Norovirus and Middle East Respiratory Syndrome (MERS), which are in pre-clinical studies. Themis recently announced a collaboration with MSD to develop undisclosed vaccine candidates. In 2018, the company initiated its immuno-oncology portfolio with the first therapeutic candidate to enter clinical studies this year. About the New Investors Farallon Capital Management, L.L.C. is a global institutional investment management firm founded in 1986. Farallon manages approximately US$ 28 billion in capital for institutions, including college endowments, charitable foundations, pension plans and sovereign wealth funds, and for high net worth individuals. Farallon is headquartered in San Francisco and has offices in London, Singapore, Hong Kong, Tokyo and São Paulo. Hadean Ventures is an Oslo and Stockholm-based life science fund manager that invests in life science companies across Europe with a particular focus on under-ventured regions. Hadean’s funds are backed by leading European and US-based private and institutional investors. Adjuvant is a New York-based life sciences fund built to accelerate the development of new technologies for the world's most pressing public health challenges. Backed by prominent investors such as the International Finance Corporation, Novartis, and the Bill & Melinda Gates Foundation, Adjuvant draws upon a global network of scientists, public health experts, biopharmaceutical industry veterans, and development finance professionals to identify and execute upon new investment opportunities. Adjuvant finances promising new vaccines, therapeutics, diagnostics, and medical devices for historically overlooked indications such as malaria, cholera, Lassa fever, and postpartum hemorrhage, among others, with a commitment to make these interventions accessible to those who need them most in low- and middle- income countries. About Themis Themis is developing immunomodulation therapies for infectious diseases and cancer. Through advanced understanding of immune system mechanisms, the Company has built a sophisticated and versatile technology platform for the discovery, development and production of vaccines as well as other immune system activation approaches. Initially focused on preventing infectious diseases, Themis has demonstrated the potential of its versatile platform through the rapid and successful completion of Phase 2 and near-term entry into Phase 3 clinical development for a vaccine against Chikungunya, a debilitating disease with global outbreak potential. Funded to date by leading venture capital firms, Themis has also gained prestigious non-dilutive funding for emerging infectious disease indications. The Company will apply its platform and commercial manufacturing capabilities to diseases with high market potential both alone and for its partners. For more information, visit http://www.themisbio.com. Contact For Themis: Media & Investor InQuiries for Themis: Erich Tauber, MD, CEO Stephanie May, PhD or Jacob Verghese, PhD Themis Trophic Communications Phone: +43 1 236 7151 Phone: +49 89 2388 7730 or +49 171 185 5682 [email protected] [email protected] .
Recommended publications
  • Golden Gate University Department of Finance and Economics FI 350 – Portfolio Management January 2007
    Golden Gate University Department of Finance and Economics FI 350 – Portfolio Management January 2007 Marty Dirks – 415-845-7829– [email protected] Elliot Blumberg – [email protected] Adjunct Professors Course Objectives This is a hands-on course, placing students in the role of an equity securities analyst and portfolio manager. As such, students will regularly submit investment ideas for in-class and online discussion. Through this process, students will enhance their ability to develop their investment analysis skills as well as communicate their investment ideas, both verbally and in writing. Students will consider all aspects of the investment evaluation process including valuation, event catalyst impact, risk management and hedging. Alternative investment strategies utilized by hedge funds will be discussed, including long-short (Jones Model), risk arbitrage, convertible arbitrage, statistical arbitrage, and trading of securities. Security selection and risk management will be examined through the use of textbook excerpts, journal articles, newspaper and magazine articles, SEC filings and written case situations. Portfolio optimization, and portfolio performance attribution and evaluation will be presented. Creating synthetic positions and risk management through use of options will be examined. Prerequisites FI 340. Basic understanding of financial accounting and equity valuation techniques. This is a “capstone” course, building concepts from many prerequisite courses. Students should be familiar with basic option theory and using option “Greeks.” Options As A Strategic Investment is on reserve in the library. Students should understand the concepts in this book prior to the lectures involving options theory. Similarly, students should be familiar with the material in an investments text such as Investment Analysis and Portfolio Management by Reilly and Brown or Investments by Bodie, Kane and Marcus.
    [Show full text]
  • Interim Report
    Hongkong Ch i n es e L i (於百慕達註冊成立之有限公司) m (Incorporated in Bermuda with limited liability) i t (股份代號: 655) e (Stock Code: 655) d 香 港 華 人有 限 公 司 201 7 Interim Re p ort 中期業績報告 中期業績報 Interim Report 告 Contents Page Condensed Consolidated Statement of Profit or Loss 2 Condensed Consolidated Statement of Comprehensive Income 3 Condensed Consolidated Statement of Financial Position 4 Condensed Consolidated Statement of Changes in Equity 6 Condensed Consolidated Statement of Cash Flows 7 Notes to the Interim Financial Statements 8 Business Review and Prospects 25 Additional Information 32 Supplementary Financial Information 43 Corporate Information 44 The Directors of Hongkong Chinese Limited (the “Company”) present the unaudited condensed consolidated interim financial statements of the Company and its subsidiaries (collectively, the “Group”) for the six months ended 30th September, 2017 (the “Period”). Condensed Consolidated Statement of Profit or Loss For the six months ended 30th September, 2017 Unaudited six months ended 30th September, 2017 2016 Note HK$’000 HK$’000 Revenue 4 54,617 145,175 Cost of sales 5 (7,843) (40,715) Gross profit 46,774 104,460 Administrative expenses (27,247) (27,430) Other operating expenses (11,694) (25,322) Net fair value gain on financial instruments at fair value through profit or loss 222 17,229 Finance costs (6,305) (53) Share of results of associates 1,841 (370) Share of results of joint ventures 6 4,780 125,610 Profit before tax 5 8,371 194,124 Income tax 7 (1,277) (7,747) Profit for the period 7,094 186,377
    [Show full text]
  • Alternative Investments 2020: the Future of Capital for Entrepreneurs and Smes Contents Executive Summary
    Alternative Investments 2020 The Future of Capital for Entrepreneurs and SMEs February 2016 World Economic Forum 2015 – All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, including photocopying and recording, or by any information storage and retrieval system. B Alternative Investments 2020: The Future of Capital for Entrepreneurs and SMEs Contents Executive summary 1 Executive summary Over the past decade, the external environment for alternative investments has seen 2 1. Introduction enormous changes. The areas affected the most are start-up capital and venture 3 1.1. Background funding for entrepreneurs, crowdfunding and marketplace lending for small businesses, 3 1.2. Scope and private debt for mid-market enterprises. 6 2. The shake-up of traditional start-up capital 6 2.1. Overview In all three cases, a set of interlocking factors is driving the emergence of new 8 2.2. What you need to know capital sources: 11 2.3. What to look out for 11 2.4. Take-away Regulation: where regulation constrains a capital flow for which there 1. is demand, a new source of capital will emerge to fulfil that demand; 12 3. The rise of crowdfunding 12 3.1. Overview 14 3.2. What you need to know Changes in demand for capital: where capital destinations develop 16 3.3. What to look out for 2. demand for new forms of funding, investors will innovate to meet it; 17 3.4. Take-away Technology: where technology enables new types of origination, 18 4. Mid-market capital 18 4.1.
    [Show full text]
  • Farallon Real Estate Partners III, L.P. Form D Filed 2019-07-12
    SECURITIES AND EXCHANGE COMMISSION FORM D Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act. Filing Date: 2019-07-12 SEC Accession No. 0001782406-19-000001 (HTML Version on secdatabase.com) FILER Farallon Real Estate Partners III, L.P. Mailing Address Business Address C/O FARALLON CAPITAL C/O FARALLON CAPITAL CIK:1782406| IRS No.: 842210599 | State of Incorp.:DE | Fiscal Year End: 1231 MANAGEMENT, L.L.C. MANAGEMENT, L.L.C. Type: D | Act: 33 | File No.: 021-344193 | Film No.: 19953013 ONE MARITIME PLAZA, ONE MARITIME PLAZA, SUITE 2100 SUITE 2100 SAN FRANCISCO CA 94111 SAN FRANCISCO CA 94111 4154212152 Copyright © 2019 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION OMB APPROVAL OMB Number: 3235-0076 Washington, D.C. 20549 June 30, Expires: FORM D 2012 Estimated average burden hours per 4.00 Notice of Exempt Offering of Securities response: 1. Issuer's Identity CIK (Filer ID Number) Previous Name(s) ☒ None Entity Type 0001782406 ☐Corporation Name of Issuer ☒ Limited Partnership Farallon Real Estate Partners III, L.P. ☐ Limited Liability Company Jurisdiction of Incorporation/ Organization ☐ General Partnership DELAWARE ☐ Business Trust Year of Incorporation/Organization ☐Other ☐ Over Five Years Ago ☒ Within Last Five Years (Specify Year) 2019 ☐ Yet to Be Formed 2. Principal Place of Business and Contact Information Name of Issuer Farallon Real Estate Partners III, L.P. Street Address 1 Street Address 2 FREP III GP, L.L.C.
    [Show full text]
  • Backer of Well-Known Hedge Funds Shuts Down - WSJ
    6/27/2019 Backer of Well-Known Hedge Funds Shuts Down - WSJ This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit https://www.djreprints.com. https://www.wsj.com/articles/backer-of-well-known-hedge-funds-shuts-down-11561564895 HEDGE FUNDS Backer of Well-Known Hedge Funds Shuts Down Adamas Partners made investments in Baupost Group, Farallon, Lone Pine Seth Klarman, chief executive oficer of The Baupost Group, speaks in New York in June 2018. Baupost was the recipient of Adamas’s biggest investment, of $100 million. PHOTO: JEENAH MOONBLOOMBERG NEWS By Rachael Levy and Dawn Lim Updated June 26, 2019 1206 pm ET Adamas Partners LLC, a $1.7 billion investment firm that invested in hedge funds including Baupost Group LLC and Farallon Capital Management LLC, is shutting down. The closure comes after Adamas’s funds lost money last year, a person familiar with the matter said. Many firms in the hedge-fund industry have faced a reckoning in the last few years, with some funds shutting down and others lowering their historically high fees to keep investors from leaving. Driving the industry’s decline has been the simple fact that many hedge funds have lagged behind the broader market. Known as funds of funds, the investment firms that promise access to hedge funds are also fighting to survive, as many investors have balked at paying them an extra layer of fees. https://www.wsj.com/articles/backer-of-well-known-hedge-funds-shuts-down-11561564895?emailToken=c1f6699cf44cc55be3490512ed79c232aOmtj7… 1/2 6/27/2019 Backer of Well-Known Hedge Funds Shuts Down - WSJ Adamas is a small Boston-based fund of funds.
    [Show full text]
  • Tipping the Scales
    GC IN-DEPTH | WOMEN IN HEDGE FUNDS Tipping the scales There are plenty of statistics highlighting the underrepresentation of women in senior roles at hedge funds, but now the industry is taking a more proactive than reactive approach to conquer inequality, writes Jonathan Watkins. his is where a statistic would usually be, highlighting the What became abundantly clear was imbalance between women and men in senior hedge that while they didn’t mind discussing Tfund positions. Right here would be another figure about the matter, just talking about the current how well that smaller percentage perform in their respective inequality and firing out statistics – such roles, and finally the question ‘so why aren’t more women as only 3% of hedge funds monitored by running hedge funds?’ would be presented. index provider HFR are run by women When reaching out to some of the most successful women – were not going to trigger the desired in the hedge fund business, I asked them if they were tired change. Those numbers certainly amplify of talking about the underrepresentation of women in hedge the need for change but they do not funds, gauging whether this was a topic covered perhaps directly ring it. too often. This is not to say that raising 16 globalcustodian.com Global Custodian | Hedge Fund Review 2015 GC IN-DEPTH | WOMEN IN HEDGE FUNDS awareness of the disparity between men and women in senior “Change has been coming more slowly than personally I roles should be scaled back, but the real story is around what would like to see.
    [Show full text]
  • CHINA BOUND Investment Banking Joint Venture with Beijing-Based China International a CONVERSATION with MILBANK TWEED’S Capital Corp., Or CICC
    REPRINTS FROM the Chinese bank on behalf of Mor- gan Stanley in setting up China’s fi rst CHINA BOUND investment banking joint venture with Beijing-based China International A CONVERSATION WITH MILBANK TWEED’S Capital Corp., or CICC. Root plans to ANTHONY ROOT buy a residence in Beijing and com- mute between Beijing and Hong Kong BY SUE-CHING JEAN CHEN IN HONG KONG when the new Beijing offi ce opens. The Deal recently spoke to him. ILBANK, TWEED, HADLEY & MC- MCLOY LLP HAS RECENTLY BEGUN The Deal: Why do you feel the need TO GET SOME BIG RETURNS ON A LONG- to set up an operation inside China? TERM BET ON CHINA. Recently, the Wall Root: All the major companies have Street law firm advised China’s second-largest gone to China in the past two years. bank, China Construction Bank, or CCB, on Deal execution is moving to China. The two investments totaling $4 billion from Bank major investment banks are moving to of America Corp. and Temasek Holdings Ltd. China. Our Hong Kong office will still BofA’s $2.5 billion contribution in June was have a Korean and a regional focus. In corporate China’s biggest-ever foreign direct the next two to five years, the main investment and the first in one of China’s big business in China will be executed out four state banks. of Beijing and Shanghai. Future growth The deal also represented a milestone in will come from China. We are setting China by being negotiated in and contracted up an office in Beijing.
    [Show full text]
  • Firm: Farallon Capital Europe LLP (“Firm”) Calendar Year Disclosure Period: 1 January 2020 to 31 December 2020 Date: 30 April 2021
    Firm: Farallon Capital Europe LLP (“Firm”) Calendar Year Disclosure Period: 1 January 2020 to 31 December 2020 Date: 30 April 2021 Summary of classes of instruments included in this report, and class of instruments not included in this report (because the Firm has not executed client orders in that class of instruments during the relevant disclosure period): Classes of instruments included in this report Classes of instruments not included in this report Equities – Shares & Depositary Receipts – Tick size liquidity Debt instruments - Money markets instruments bands 5 and 6 (from 2000 trades per day) Interest rates derivatives - Swaps, forwards, and other interest Equities – Shares & Depositary Receipts – Tick size liquidity rates derivatives bands 3 and 4 (from 80 to 1999 trades per day) Credit derivatives - Futures and options admitted to trading on a Equities – Shares & Depositary Receipts – Tick size liquidity trading venue bands 1 and 2 (from 0 to 79 trades per day) Currency derivatives - Futures and options admitted to trading Debt instruments - Bonds on a trading venue Credit derivatives - Other credit derivatives Currency derivatives - Swaps, forwards, and other currency derivatives Equity Derivatives - Options and Futures admitted to trading on a trading venue Structured finance instruments Equity Derivatives - Swaps and other equity derivatives Securitized Derivatives - Warrants and Certificate Derivatives Interest rates derivatives - Futures and options admitted to trading Securitized Derivatives - Other securitized derivatives on a trading venue Exchange traded products (Exchange traded funds, exchange Commodities derivatives and emission allowances Derivatives - traded notes and exchange traded commodities) Options and Futures admitted to trading on a trading venue Commodities derivatives and emission allowances Derivatives - Other commodities derivatives and emission allowances derivatives 1 Contracts for difference Emission allowances Other instruments 1.
    [Show full text]
  • April 13 2021 Investment Committee Meeting Public Packet
    INVESTMENT COMMITTEE MEETING VIRTUAL April 13, 2021 at 9:00 AM MT COMMITTEE MEMBERS Steve Neel, Chair Paula Fisher, Vice-Chair Lawrence Davis Loretta Naranjo-Lopez Diana Rosales-Ortiz AGENDA 1. Roll Call 2. Approval of Agenda 3. Approval of Consent Agenda 4. Current Business ITEM PRESENTER A Performance & Risk Update Thomas Toth Wilshire 1. Information Item: February 2021 Preliminary Flash Performance B Active Risk Budget Update Part II Thomas Toth Wilshire 1. Information Item: Portable Alpha Review James Walsh Albourne Dominic Garcia Chief Investment Officer C Asset Class Review & Update Thomas Toth Wilshire 1. Information Item: Risk Reduction & Mitigation Dominic Garcia Chief Investment Officer 5. Adjournment Consent Agenda Approval of minutes of March 25, 2021 Investments Committee meeting. Any person with a disability who needs a reader, amplifier, qualified sign language interpreter, or any other form of auxiliary aid or service to attend or participate in the hearing or meeting, please contact Trish Winter at (505) 476-9305 at least one week prior to the meeting, or as soon as possible. Public documents, including the agenda and minutes, can be provided in various accessible formats. Please contact Trish Winter if a summary or other type of accessible format is needed. Francis Page P: (505) 476-9300 Acting Board Chair, Retiree Member F: (505) 476-9401 Toll Free: Greg Trujillo 1(800) 342-3422 Acting Executive Director TUESDAY, APRIL 13, 2021 9:00AM MT INVESTMENT COMMITTEE 9:00AM MT AUDIT & BUDGET COMMITTEE FOLLOWING INVESTMENT COMMITTEE
    [Show full text]
  • Lehman Brothers Offshore Diversified Arbitrage Fund II, Ltd. SEPTEMBER 2007
    Lehman Brothers Offshore Diversified Arbitrage Fund II, Ltd. SEPTEMBER 2007 INVESTMENT STYLE FUND STRATEGY Fund of Hedge Funds To seek long-term capital appreciation while attempting to reduce risk and volatility by seeking • Arbitrage consistent, positive absolute returns with low market correlation. The portfolio invests in hedge funds • Event Driven managing arbitrage and event driven strategies. 1 FUND PROFILE FUND PERFORMANCE & STATISTICS (net of fees ) Monthly Returns FUND INCEPTION: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec YTD August 2004 2007 1.68 1.21 0.85 1.30 1.53 0.54 0.23 (1.82) 0.79 0.00 0.00 0.00 6.45% STRATEGY ASSETS: 2006 2.75 0.63 1.19 2.06 (0.42) (0.15) 0.20 0.66 (1.03) 1.46 1.32 1.55 10.63% $2,066 million 2005 0.25 0.60 0.07 (0.82) (0.57) 0.71 1.54 0.53 1.05 (0.42) 0.70 1.28 5.01% 2004 1.44 0.76 0.45 0.03 (0.07) (0.01) 0.17 0.14 0.37 0.42 1.64 0.98 6.50% SHARE CLASS: 2003 1.63 0.64 0.38 1.47 1.24 0.72 0.29 0.29 1.02 0.91 0.66 0.58 10.28% Class A and Class B 2002 0.73 (0.04) 0.76 0.59 0.16 (1.52) (2.14) 0.39 (0.21) 0.19 1.75 1.02 1.65% SUBSCRIPTION: Fund S&P 500 LB U.S.
    [Show full text]
  • Value Creation of Hedge Fund Activism and the Impact on Long Term Returns and Volatility of the Target Company
    Paul Rintamäki 365143 Value creation of hedge fund activism and the impact on long term returns and volatility of the target company ABSTRACT This study provides new evidence on value creation ability of hedge fund activism and its effects on target firm’s riskiness and long-term returns. With the data-set from SEC Edgar 13D filings 215 events were identified and tested about the common beliefs that hedge fund activism increases the medium- and long term volatility of the target and adversely affects target company’s long term returns. The findings suggest that neither belief is supported by the data. In fact, targets are able to maintain the abnormal returns in the long term as well, which indicate about the value creation ability of hedge fund activists. The results are mainly consistent with existing literature but also offer some new evidence about negative correlation between target firms’ returns and the value premium after the activist intervention. Finance Bachelor’s thesis Autumn 2016 Table of Contents 1 Introduction ........................................................................................................................ 3 2 Literature review ................................................................................................................. 4 2.1 Value creation or stock picking? ........................................................................................................ 4 2.2 Long term effects and changes in firm’s riskiness ............................................................................
    [Show full text]
  • Propitch Presentation
    Evolution of the Capital Stack and the Tectonic Shift of the Players at the Table (Fundamental Changes) October 10, 2017 Executive Summary . In the past, commercial banks syndicated and held loans; investment banks underwrote and sold bonds . Banks today originate and sell and rarely retain exposure to corporate credit. This is primarily due to increased regulation and increased capital requirements, but was also happening after mega-mergers between investment and commercial banks prior to the crisis . As interest rates have compressed over the past 10 years, there has been an increased demand for yield and accordingly the markets for high yield bonds and levered loans have grown significantly . At the same time, borrowers have used the proceeds to refinance debt at lower interest rates and for acquisitions to stimulate revenue and earnings growth [ 1 ] Executive Summary . Firms like Blackrock, Fidelity and Pimco have grown assets, Collateralized Loan Obligations (CLOs) and Business Development Companies (BDCs) have emerged as significant originators, and large institutional asset management firms and hedge fund capital have grown ―These institutions have been the buyers of new credit issues ―They own credit through an economic cycle and are often now the largest constituencies in in-court and out-of-court balance sheet restructuring ―Their interests, regulatory and contractual restrictions, and time horizons on investments have changed the landscape in the restructuring and bankruptcy community along with the increased presence of distressed credit hedge funds in capital structures [ 2 ] Classic Model of Debt Origination / Issuance Classic Bank Loan Model – Commercial Bank Centric Classic Bond Issuance Model – Investment Bank Centric .
    [Show full text]